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While weight gain is clearly promoted by excessive energy intake and reduced
expenditure, the underlying neural mechanisms of energy balance remain unclear.
The nucleus accumbens (NAc) is one brain region that has received attention for its
role in the regulation of energy balance; its D1 and D2 receptor containing neurons
have distinct functions in regulating reward behavior and require further examination.
The goal of the present study is to investigate how activation and inhibition of
D1 and D2 neurons in the NAc influences behaviors related to energy intake and
expenditure. Specific manipulation of D1 vs. D2 neurons was done in both low
expenditure and high expenditure (wheel running) conditions to assess behavioral
effects in these different states. Direct control of neural activity was achieved using a
designer receptors exclusively activated by designer drugs (DREADD) strategy. Activation
of NAc D1 neurons increased food intake, wheel running and locomotor activity. In
contrast, activation of D2 neurons in the NAc reduced running and locomotion while
D2 neuron inhibition had opposite effects. These results highlight the importance
of considering both intake and expenditure in the analysis of D1 and D2 neuronal
manipulations. Moreover, the behavioral outcomes from NAc D1 neuronal manipulations
depend upon the activity state of the animals (wheel running vs. non-running). The
data support and complement the hypothesis of specific NAc dopamine pathways
facilitating energy expenditure and suggest a potential strategy for human weight
control.
Keywords: nucleus accumbens, medium spiny neurons, designer receptors exclusively activated by designer
drugs (DREADD), running, locomotion, food intake, energy expenditure, exercise
INTRODUCTION
Obesity is a complex disease that burdens individuals and health care systems. In a simplified view,
energy intake and expenditure need to be balanced to maintain a normal body weight. Excess
intake of high calorie food and reduced activity due to sedentary lifestyle have contributed to
the increase in obesity rates (Prentice and Jebb, 2004; Garland et al., 2011). While controlling
food intake and engaging in vigorous exercise is a clear strategy for weight loss, it is very
difficult to achieve and maintain (Finlayson et al., 2011; Swift et al., 2014). A better description
of neural mechanisms controlling intake and activity, and how these are integrated, is needed.
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The dopamine system, especially the nucleus accumbens
(NAc), is a potential neural substrate that can control
both sides of the energy balance equation. In terms of
energy intake, the NAc is known to regulate feeding.
For example, food intake can be induced by blockade of
specific glutamate receptors (Maldonado-Irizarry et al.,
1995) or activation of mu opioid receptor (MOR; Zhang
et al., 1998) in the NAc. In addition, local infusion of
psycho-stimulant drugs, such as dopamine (Campbell
et al., 1997), cocaine (Delfs et al., 1990), and amphetamine
(Essman et al., 1993), into the NAc has long been known to
increase locomotor activity. These data have led to models
where that the NAc has a role in energy homeostasis by
integrating intake and expenditure to adapt to environmental
conditions (Beeler et al., 2012; Salamone and Correa,
2012).
How energy intake and activity-mediated expenditure
are regulated and coordinated by neurons in the NAc
remains unclear. Most neurons in the NAc are medium
spiny neurons (MSNs), which can be divided into two major
categories: dopamine receptor 1-like containing neurons
(D1 neurons) and dopamine receptor 2-like containing
neurons (D2 neurons; Albin et al., 1989; DeLong, 1990;
Gerfen et al., 1990). D1 and D2 neurons in the NAc are
physically intermingled and morphologically indistinguishable.
Extensive studies using pharmacology have yielded inconsistent
data on the role of D1 and D2 NAc neurons in food
intake, and few studies have evaluated both activity and
intake after NAc D1 and D2 manipulations (Baldo et al.,
2002).
In this study, we assessed the effects of activation and
inhibition of NAc D1 and D2 neurons on energy intake and
activity-based expenditure. We used wheel running in addition
to a locomotor activity assay to determine effects of D1
and D2 neuron manipulations on different types of activity.
Notably, wheel running is rewarding and reinforcing for rodents,
including wild strains (Sherwin, 1998; Meijer and Robbers, 2014)
and has been proposed to parallel human voluntary exercise
(Eikelboom, 1999; Rezende et al., 2009; Kelly et al., 2010;
Garland et al., 2011). By measuring activity and intake in both
running and non-running conditions, we are able to evaluate
the role of D1 and D2 neurons on these different expenditure
behaviors.
To achieve direct neuronal control and specificity, we
employed D1 and D2-Cre mice together with designer
receptors exclusively activated by designer drugs (DREADD)
technology (Armbruster et al., 2007). DREADDs are genetically
modified from the G-protein-coupled muscarinic receptor
such that they are solely activated by clozapine-N-oxide
(CNO), an otherwise pharmacologically inert compound,
with high potency and efficacy. By locally injecting adeno-
associated virus (AAV, serotype 2) expressing Gq (hM3Dq)
or Gi (hM4Di)-coupled Cre-inducible DREADD into the
NAc of D1 or D2-Cre mice, we achieved specific control
(activation or inhibition) of each population of neurons




D1-Cre (strain EY262, Gensat) andD2-Cre (strain ER44, Gensat)
mice were maintained on a C57BL/6J background. Experiments
were started when animals were 10–33 weeks of age. Within each
group the maximum age difference was less than 4 weeks and the
total animals used for analysis were: D1-Cre Gq n = 8, D1-Cre Gi
n = 8, D2-Cre Gq n = 5, and D2-Cre Gi n = 14. We did not detect
significant behavioral differences between males (n = 23) and
females (n = 12) in the study, and data from both sexes were used.
All procedures were approved by the Yale Institutional Animal
Care and Use Committee.
Virus Expression
We used commercially available AAV-hSyn-DIO-hM3D(Gq)-
mCherry and AAV-hSyn-DIO-hM4D(Gi)-mCherry, obtained
from UNC Gene Therapy Center Vector Core.
Stereotaxic Surgery
A mixture of ketamine (100 mg/kg body weight) and xylazine
(10 mg/kg body weight) delivered via intraperitoneal (i.p.)
injection was used for anesthesia. Animals were placed in
a stereotaxic frame (Stoelting, Wood Dale, IL, USA). After
craniotomy, viruses were injected into the NAc bilaterally (0.5
µl/side) through a 32 gauge syringe over 5 min at the following
coordinates (all values given relative to bregma): +1.4mm rostral,
±0.7 mm lateral,−4.5 mm ventral. Mice recovered for 2–3 weeks
to allow for optimal virus expression before the initiation of
behavioral studies.
Wheel Running
The mice were maintained on a 12 h light/dark cycle, with
lights on at 7 A.M. and lights off at 7 P.M., and had ad libitum
access to water, food, and running wheels with a diameter of 11
cm, corresponding to 0.3454m per revolution. At least 14 days
of voluntary wheel running were allowed in order to stabilize
running and intake before the test period. Rotation counts
were recorded by ‘‘clocklab’’ software (Actimetrics, Wilmette, IL,
USA). Saline was given i.p. (0.1 ml/10 g body weight) first and
10 mg/kg CNO was injected the following day. Injections were
performed 2 h prior to onset of dark cycle. These procedures
were completed three times with 2–3 days between repeats,
and data collected from saline and CNO days were averaged
for within-subject comparison. Due to equipment malfunction,
two mice from the D1-Cre Gi cohort were excluded from the
pre-treatment wheel running and the concurrent intake analysis
(Figure 1). Additionally, one mouse from the D1-Cre Gq, and
one mouse from the D2-Cre Gq cohort were excluded from the
wheel running and the concurrent intake analysis (Figures 2A,B,
3A,B).
Locomotor Activity Assay
All mice were habituated to the locomotor chambers (Med
Associates, St. Albans, NY, USA) for 1 day prior to treatment with
the same light/dark cycle as in wheel running period. Following
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FIGURE 1 | Running distance and food intake increase and stabilize
during the 14-day exposure to running wheels. (A) All four groups of
animals in this study rapidly adapted to wheel running and average daily
running distance was 2.71 ± 0.14 km on Day 1 and 9.72 ± 0.16 km on Day
14. (B) Average daily food intake across four groups of animals was
4.38 ± 0.73 g on Day 0 (the day before onset of wheel access), 5.48 ± 0.97 g
on Day 1 and 6.10 ± 0.26 g on Day 14. D1 Gq stands for the cohort of
D1-Cre mice with Gq-coupled DREADD expression in the NAc (n = 7). Similar
abbreviations are used for D1 Gi (n = 6), D2 Gq (n = 5), and D2 Gi (n = 14).
habituation day, saline i.p. (0.1 ml/10 g body weight) injection
was conducted 2 h prior to onset of dark cycle. 10 mg/kg CNO
was injected at the same time the next day and locomotor activity
was recorded in 30 min bins. Data from some animals were
excluded from analysis of locomotion and corresponding intake
due to technical artifacts (1 in D1-Cre Gq, 1 in D1-Cre Gi, 0 in
D2-Cre Gq, 3 from D2-Cre Gi; Figures 4, 5).
Statistical Procedures
GraphPad Prism 6.0 was used to calculate statistical tests. To
analyze the within-subject difference between treatments (saline
vs. CNO), all t-tests performed were two-tailed, paired. When
applicable, two-way ANOVAs with repeated measurements were
assessed and post hoc analyses were conducted. All error bars
shown in the graphs represent± SEM.
Immunofluorescence for Viral Infection
Assessment
D1/2-Cre C57BL/6J transgenic mice were deeply anesthetized
and intra-cardially perfused using 10% formalin. Following
30% sucrose cryoprotection, the brain was sectioned at
40 µm thickness on a freezing microtome and stored in
1 × PBS with 0.01% sodium azide to prevent bacterial growth.
Immunofluorescence was performed by pretreating sections
in 2% Triton X-100/1 × PBS for 30 min before blocking
buffer incubation for 60–90 min (3% donkey serum, 0.3%
Triton X-100, 1 × PBS). Primary antibody (anti-DsRed, 1:500,
Clontech, Palo Alto, CA, USA) was diluted accordingly in
blocking buffer and sections were incubated overnight at room
temperature. After 2 h incubation of secondary antibody (donkey
anti-rabbit, Alexa Fluor 555, 1:500, Life Technologies, Carlsbad,
CA, USA), tissue was visualized and images were captured with
a fluorescent microscope (Zeiss, Thornwood, NY, USA) using
standard TRITC filters.
RESULTS
NAc D1 Activity Positively Regulates Food
Intake During Wheel Running
The D1-Cre mice with Cre-inducible Gq or Gi-DREADD
expression in the NAc were given access to wheels for at least
14 days before saline or CNO administration. For both D1-Cre
Gq and Gi cohorts, total running distance increased during
the entire period (Figure 1A) while food intake also increased
and then stabilized after the first few days (Figure 1B). Saline
or CNO was injected i.p. 2 h before onset of the dark cycle
on respective days, and daily running distance and food intake
were measured on three separate trials. When D1 neurons
expressing Gq-DREADD in the NAc were activated with CNO
administration, mice increased running distance (Figure 2A)
over 24 h accompanying an increase in food intake during the
same period (Figure 2B). In contrast, when NAc D1 neurons
expressing Gi-DREADD were inhibited with CNO, the mice
decreased food intake (Figure 2D) but running distance over
24 h after injection was not affected (Figure 2C). These data
are consistent with a role for D1 neurons in both intake and
expenditure (Baldo et al., 2002) in wheel running mice.
D2 Neurons in the NAc Bi-Directionally
Regulate Running Distance Without
Affecting Food Intake
The same tests were performed on D2-Cre mice with Cre-
inducible Gq/Gi-DREADD expression in the NAc. Here, the
activity of D2 neurons in the NAc negatively correlates with
running distance. When mice with Gq-DREADD in D2 neurons
were treated with CNO, running distance over 24 h after injection
was reduced (Figure 3A), whereas CNO treatment of D2-Cre,
Gi-DREADD mice increased running distance (Figure 3C). In
both cases, food intake during the same time was not affected
(Figures 3B,D). These results suggest a more prominent role
of NAc D2 neurons in activity rather than intake under wheel
running conditions.
Activation of D1 Neurons in the NAc Briefly
Elevates Locomotion
Animals were habituated in locomotor test boxes (without
wheels) for 1 day and then were given saline injection i.p.
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FIGURE 2 | Activation of D1 neurons in the nucleus accumbens (NAc) increases food intake and running distance, while inhibition of D1 neurons
suppresses food intake without effecting running distance. D1-Cre mice with Cre-inducible Gq-DREADD expression in the NAc were given access to wheels
for 2 weeks of training. Saline or clozapine-N-oxide (CNO) was injected i.p. 2 h before the onset of the dark cycle on two consecutive days, and running distance and
food intake over 24 h after injection were assessed. (A) Activation of D1 neurons in the NAc increased running distance (paired t test *P = 0.0007, n = 7) and food
intake (paired t test *P = 0.0008, n = 7) during 24 h after injection (B). (C) Inhibition of D1 neurons in the NAc did not change running distance but decreased food
intake (D) over 24 h (paired t test *P = 0.0026, n = 8).
on the next day. On the third day, CNO was administered
and D1-Cre animals with Gq-DREADD exhibited a near
significant increase (P = 0.06) in 24 h locomotor activity
(Figure 4A) with clear effects in the first 6 h (Figure 4B).
Surprisingly, food intake during the same 24 h period was
reduced (Figure 4C), and the reduction occurred in later
hours within the test period (food intake 0–6 h after injection
was 2.44 ± 0.11 g on saline day vs. 2.61 ± 0.31 g on CNO day,
paired t test P = 0.62; food intake 6–24 h after injection was
3.36± 0.18 g on saline day vs. 2.07± 0.32 g on CNO day, paired
t test *P = 0.0042). Conversely, when NAc D1 neurons were
inhibited, neither food intake nor locomotor activity was affected
(Figures 4D–F).
NAc D2 Activity Level Inversely Regulates
Locomotion Without Affecting Food Intake
We performed the same experiment to examine the effects
of activation and inhibition of D2 neurons on locomotion
and intake. Similar to the results from the wheel running
condition, activation of D2 neurons with Gq-DREADD
in the NAc suppressed total locomotion over 24 h after
injection (Figure 5A) with the strongest effects between
3–9 h (Figure 5B). In contrast, inhibition of D2 neuron
activity in the NAc with Gi-DREADD increased total
locomotion over 24 h after injection (Figure 5D) with the
strongest effects in the first 6 h (Figure 5E). No difference
in food intake was found during the same 24 h periods
(Figures 5C,F).
Viral Expression Assessment
All brains were perfused and sectioned and immunofluorescence
was performed to confirm the placement of viral expression.
Figure 6A is a representative image showing bilateral targeting in
the NAc, in which the red area represents expression ofmCherry-
tagged Cre-inducible DREADD virus. Animals with bilateral hits
as shown in Figure 6B (red outlines) were included for analysis.
All animals had expression in the shell region and most also had
expression in the core.
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FIGURE 3 | Activation of D2 neurons in the NAc suppresses running without affecting food intake, while inhibition of D2 neurons increases running
without effects on intake. The same experimental procedures in Figure 2 were performed on D2-Cre mice with Cre-inducible Gq/Gi-DREADD expression in the
NAc. (A) 24 h running distance was suppressed by activation of D2 neurons in the NAc (paired t test *P = 0.0054, n = 4) while food intake was not affected (B).
(C) 24 h running distance was increased by inhibition of D2 neurons in the NAc (paired t test *P = 0.0014, n = 14) with no effects on food intake (D).
DISCUSSION
In the present study, we have demonstrated that D1 and
D2 neurons in the NAc play different roles in modulating
energy balance and that these effects vary depending on the
environment. With wheel access, activity of D1 neurons in
the NAc mainly controls food intake while NAc D2 neuron
manipulations affect running distance. When wheels are not
available, activation and inhibition of D2 neurons in the NAc still
bi-directionally modulates locomotor activity without affecting
intake while activation of D1 influences both locomotion and
food intake.
The cellular (D1 vs. D2) and regional (NAc) specificity of
the present study helps to complement and clarify some of
the present literature on dopamine pathways. The canonical
view of motor control in the dorsal striatum suggests that
the neural activity in the direct pathway (D1 neurons)
enhances movement, while neural activity in the indirect
pathway (D2 neurons) inhibits movement (Albin et al.,
1989; Gerfen et al., 1990). This view is supported by direct
manipulations of these populations in the dorsal striatum
(Kravitz et al., 2010). This opposing action is consistent
with our finding here that activation of the ventral striatal
D1 neurons promoted both running and general locomotion
while activation of NAc D2 neurons inhibited running and
locomotion. While direct manipulation of NAc neurons during
running has not been previously reported, over-expression of
deltaFosB within the direct pathway of the NAc and dorsal
striatum increases running, whereas deltaFosB overexpression
within the indirect pathway decreases running (Werme et al.,
2002).
Contrasting Effects of NAc D1 and D2
Neuron Activation in Regulating Energy
Balance During Wheel Running
Studies using systemic administration of dopamine agonists or
antagonists have produced conflicting results on the role of
dopamine receptors in running. Rhodes et al., found that D1
and D2 antagonists reduced running distance in a strain of
selective high runners (Rhodes et al., 2001; Rhodes and Garland,
2003) while Knab et al. (2012) showed that D1 agonist, but
Frontiers in Behavioral Neuroscience | www.frontiersin.org 5 April 2016 | Volume 10 | Article 66
Zhu et al. NAc D1/2, Running, Locomotion, Intake
FIGURE 4 | Activation of D1 neurons in the NAc decreases intake accompanying a mild increase in locomotion, while inhibition of D1 neurons in the
NAc has no effects on locomotion and intake. (A) CNO activation of Gq-DREADD in the D1 neurons in the NAc tended to induce locomotion (paired t test
P = 0.06, n = 7) over 24 h after injection and locomotor elevation (B) was robust during 0.5∼3.5 h after injection (F(47,564) = 5.877, *P < 0.0001, Bonferroni’s post
hoc: *P < 0.05 over bin 2∼7, saline baseline vs. CNO treatment). (C) Food intake was decreased during 24 h after injection (paired t test *P = 0.0007, n = 7).
(D,E) CNO activation of Gi-DREADD in the D1 neurons in the NAc (n = 7) did not change locomotor activity over 24 h, and did not affect food intake (F). Black bars
represent dark period and white bars represent light period.
not D1 antagonist, reduced running distance in a different
strain of high running mice. These studies highlight genetic
variations that are of importance, but do not identify specific
neural circuits mediating the effects of dopamine. Moreover,
the effects of pharmacological reagents on neural activity are
often complex. The present use of DREADD-expressing viruses
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FIGURE 5 | Activation of D2 neurons in the NAc suppresses locomotion without affecting food intake, while inhibition of D2 neurons increases
locomotion without effects on intake. (A) CNO activation of Gq-DREADD in the D2 neurons in the NAc reduced total locomotor activity over 24 h (paired t test
*P = 0.0064, n = 5), with the most robust effect during 2.5∼9 h after injection (F(47,376) = 7.474, *P < 0.0001, Bonferroni’s post hoc: *P < 0.05 over bin 5∼18, saline
baseline vs. CNO treatment) (B). (C) Food intake during 24 h after activation of D2 neurons was not affected. (D) CNO activation of Gi-DREADD in the D2 neurons in
the NAc robustly induced locomotion over 24 h (paired t test *P = 0.0005, n = 11), with the most robust effect during 2.5∼6.5 h after injection (F(47,940) = 3.789,
*P < 0.0001, Bonferroni’s post hoc: *P < 0.05 in bins 5–11) (E). (F) Food intake was not affected during 24 h after CNO injection. Black bars represent dark period
and white bars represent light period.
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FIGURE 6 | Assessments of placements and viral expression in the NAc. (A) Representative micrograph shows the expression and distribution of
Cre-inducible DREADD virus with mCherry (red). DAPI (blue) depicts the brain coronal section containing the NAc. (B) Schematic drawing of the viral expression
distribution across all four cohorts of animals. Red areas circled by solid lines indicates the common region with expression in each individual while the area circled by
dashed lines shows the largest viral expression area among all animals used in this study. AcbSh and AcbC, shell and core regions of the NAc, respectively; Aca,
anterior commissure.
allowed for specific manipulation of D1 and D2 neural activity
within the NAc and demonstrates that NAc D1 neurons
play a dominant role in controlling food intake while NAc
D2 neurons primarily regulate wheel running distance. These
effects help to identify likely neural mechanisms by which
dopamine influences both intake and activity. For example,
high NAc dopamine would increase food intake via D1 neuron
activation while also increasing energy expenditure via D2
neuron inhibition. In contrast, when dopamine is low in the
NAc, the present data suggest that lower D1 and higher D2
neuron activity would cause reduction in both energy intake and
expenditure.
Opposite Effect of NAc D1 and D2 Neurons
on Locomotion
When wheels are not accessible, activity changes of both
D1 and D2 neurons in the NAc affect general locomotion.
Activation of NAc D1 neurons transiently increased locomotion,
while D2 neuron activation decreased locomotion. These results
are in agreement with the study by Baldo et al. (2002) where
they found that D1 and D2 antagonist delivered into NAc
could reduce ambulatory locomotion with more pronounced
effect by the D1 antagonist. In the present study, D1 neuron
activation reduced intake in non-running conditions while
D1 neuron inhibition had no effect on intake. However, the
subtle changes in meal patterns reported by Baldo et al. (2002)
after D1 antagonist treatment might not be seen in our study
design.
The effects of D1 and D2 stimulation in the non-running
condition are consistent with the hypothesis of dopamine
facilitating energy expenditure (Beeler et al., 2012; Salamone
and Correa, 2012). As stated by Beeler et al. (2012), under
conditions where the energy supply is plenty, elevated dopamine
would promote exploration and energy expenditure. The present
work demonstrates how D1 and D2 neurons would mediate
these effects since activation of NAc D1 neurons and inhibition
of NAc D2 neurons mainly elevated locomotion (energy
expenditure) without increasing intake. In contrast, decreased
dopamine, likely causing D1 neuron inhibition and D2 neuron
disinhibition, was hypothesized to reduce locomotion and energy
expenditure. The results here suggest that under non-running
conditions, the influence of reduced dopamine on activity
may be D2 neuron mediated. The reduction in food intake
following D1 neuron activation (Figure 4C) is also consistent
with higher expenditure-related behavior during conditions
of higher dopamine. It is notable that this reduced intake
occurred at a later time after CNO administration (6–24 h
post-injection), suggesting a delayed response to D1 neuronal
activation.
The notable baseline differences between Gq and Gi groups
could be due to the viruses or other environmental variables (e.g.,
age differences, temperature, season). We acknowledge this and
did not compare between groups but rather completed within-
subject analysis to determine the effect of D1/2 neuronal activity
changes.
Activity Changes of NAc Neurons Result in
Different Outcomes Under Different
Environmental Contexts
As obesity and related diseases have become more prevalent
in Western societies, increase in sedentary lifestyles, as well as
dietary changes, have been identified as potential causes. In
the present study, we employed two behavioral environments:
one had wheel access with running distance measured for
energy expenditure while the other was a standard home
cage with expenditure assessed by locomotor activity. We
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were able to observe different behavioral outcomes under
these distinct expenditure conditions. It should be noted
that the energy expenditure condition used here, chronic
running, might lead to specific physiological adaptations
that are not seen under all ‘‘high expenditure’’ conditions
(e.g., exploration of new space). For D1 neurons, inhibition
decreases intake under high expenditure conditions with no
effect in low expenditure conditions. This has implications
for how we might view interventions to influence food intake,
and potentially body weight, in people with different levels
of expenditure. In contrast, the D2 neuron manipulations
highlight this pathway as a potentially better target for
activity control under both high and low expenditure
conditions. That is, specific inhibition of NAc D2 neurons
would increase the amount of daily activity or exercise
without affecting food intake, which could aid weight
control.
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